BioAge Labs, Inc.
BIOA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001709941
No open-market purchases or sales by BioAge Labs, Inc. insiders were filed in the last 90 days; 150 institutions reported holding it in 13F filings for Q2 2026, worth $924.6M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding BioAge Labs, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 67 | 83 | +16 |
| Shares | 20.3M | 20.7M | +437.8K (+2.2%) |
| Value | $76.2M | $85.6M | +$9.40M (+12.3%) |
New holders (25)
Institutions that held BioAge Labs, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (9)
Institutions that held BioAge Labs, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Suvretta Capital Management, LLC | 1,452,336 | $5.46M |
| Ra Capital Management, L.P. | 1,052,494 | $3.96M |
| RTW Investments, LP | 786,353 | $2.96M |
| Howard Hughes Medical Institute | 113,765 | $427.8K |
| FIL Ltd | 82,991 | $312.0K |
| Bailard, Inc. | 25,700 | $96.6K |
| Corebridge Financial, Inc. | 5,945 | $22.4K |
| Caitong International Asset Management Co., Ltd | 2,277 | $8.56K |
| Boston Private Wealth LLC | 300 | $1.13K |